Gland Pharma files DRHP with SEBI EP News Bureau Jul 11, 2020 The Initial Public Offer (IPO) comprises of a fresh issue aggregating up to Rs. 12,500 million (the “Fresh Issue”) and an offer…
Gland Pharma launches of the first non-frozen ready-to-use Bivalirudin EP News Bureau Jun 8, 2020 Bivalirudin RTU Injection is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention
